Is the CDC’s approval of COVID-19 the end of adult approval? And what about the other vaccines Pfizer-BioNTech and Moderna have created for young children? Here are a few quick facts. The CDC recently approved the COVID-19 vaccine for children aged five to eleven years. And there’s more. Read on for more facts about these and other vaccines.
CDC’s approval of COVID-19 vaccine
Despite the controversy surrounding the new vaccine, it remains the most effective weapon against COVID-19. The CDC is set to consider approving the first COVID-19 vaccine for kids under the age of five. Approval would mark a significant milestone in our nation’s fight against the virus, and would make the COVID-19 vaccine available for nearly every American.
Vaccines for children ages 5 to 11
President Biden recently said that vaccines for children ages five to eleven will soon be available to the general public. The vaccine for hepatitis A is now approved for use in children as early as six months old. While the vaccine for hepatitis B is not approved for pediatric use, the administration of the lower-dose shots to children is a welcome step. Vaccines for children will require that the government increase the number of children participating in the clinical trial.
Pfizer-BioNTech
The new Pfizer-BioNTech vaccine was approved by the Food and Drug Administration. The FDA reviewed a study that included more than two thousand children aged 12 to 15 in the U.S. Half of the children received the vaccine while the other half received a placebo shot. Among the children who received the Pfizer-BioNTech vaccine, a total of 1,005 showed no signs of the disease after the second dose. Veterinary Vaccination Formulation Support has been deemed 100% effective in this age group.
Moderna
A debate is brewing over the use of vaccines for children. Moderna is seeking to expand use of the COVID-19 vaccine to younger children and hopes to introduce the new shot to millions of children by summer. However, the company’s product has yet to receive FDA approval for use in children younger than six. Teenagers have also experienced heart inflammation after receiving the Moderna vaccine, which has a higher dose than Pfizer’s vaccine.
Johnson & Johnson
Could Johnson & Johnson Youth Innovative Formulations for Mass Vaccination in Schools Mean the End to Adult Approval? Recently, an independent panel of the U.S. Food and Drug Administration voted 17-0 to recommend approving the COVID-19 vaccine for children ages five to 11. The vote will have a major impact on the lives of kids from the age of five to eleven.
